Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis DN O’Dwyer, SL Ashley, SJ Gurczynski, M Xia, C Wilke, NR Falkowski, ... American journal of respiratory and critical care medicine 199 (9), 1127-1138, 2019 | 274 | 2019 |
Plasma surfactant protein-D, matrix metalloproteinase-7, and osteopontin index distinguishes idiopathic pulmonary fibrosis from other idiopathic interstitial pneumonias ES White, M Xia, S Murray, R Dyal, CM Flaherty, KR Flaherty, BB Moore, ... American journal of respiratory and critical care medicine 194 (10), 1242-1251, 2016 | 169 | 2016 |
Noninvasive imaging biomarker identifies small airway damage in severe chronic obstructive pulmonary disease DM Vasilescu, FJ Martinez, N Marchetti, CJ Galbán, C Hatt, CA Meldrum, ... American journal of respiratory and critical care medicine 200 (5), 575-581, 2019 | 137 | 2019 |
Idiopathic pulmonary fibrosis: the association between the adaptive multiple features method and fibrosis outcomes ML Salisbury, DA Lynch, EJR Van Beek, EA Kazerooni, J Guo, M Xia, ... American journal of respiratory and critical care medicine 195 (7), 921-929, 2017 | 135 | 2017 |
Utility of transbronchial vs surgical lung biopsy in the diagnosis of suspected fibrotic interstitial lung disease JS Sheth, JA Belperio, MC Fishbein, EA Kazerooni, A Lagstein, S Murray, ... Chest 151 (2), 389-399, 2017 | 114 | 2017 |
Idiopathic pulmonary fibrosis: gender-age-physiology index stage for predicting future lung function decline ML Salisbury, M Xia, Y Zhou, S Murray, N Tayob, KK Brown, AU Wells, ... Chest 149 (2), 491-498, 2016 | 99 | 2016 |
Inhibition of Neutrophil Extracellular Trap Formation after Stem Cell Transplant by Prostaglandin E2 R Domingo-Gonzalez, GJ Martínez-Colón, AJ Smith, CK Smith, ... American journal of respiratory and critical care medicine 193 (2), 186-197, 2016 | 93 | 2016 |
Development and validation of a radiological diagnosis model for hypersensitivity pneumonitis ML Salisbury, BH Gross, A Chughtai, M Sayyouh, EA Kazerooni, ... European Respiratory Journal 52 (2), 2018 | 80 | 2018 |
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes DN O’Dwyer, KC Norman, M Xia, Y Huang, SJ Gurczynski, SL Ashley, ... Scientific reports 7 (1), 46560, 2017 | 69 | 2017 |
Predictors of idiopathic pulmonary fibrosis in absence of radiologic honeycombing: a cross sectional analysis in ILD patients undergoing lung tissue sampling ML Salisbury, M Xia, S Murray, BJ Bartholmai, EA Kazerooni, CA Meldrum, ... Respiratory medicine 118, 88-95, 2016 | 58 | 2016 |
Six-SOMAmer index relating to immune, protease and angiogenic functions predicts progression in IPF SL Ashley, M Xia, S Murray, DN O’Dwyer, E Grant, ES White, KR Flaherty, ... PLoS One 11 (8), e0159878, 2016 | 51 | 2016 |
Quantitative emphysema on low-dose CT imaging of the chest and risk of lung cancer and airflow obstruction: an analysis of the national lung screening trial WW Labaki, M Xia, S Murray, CR Hatt, A Al-Abcha, MC Ferrera, ... Chest 159 (5), 1812-1820, 2021 | 46 | 2021 |
Lung dysbiosis, inflammation, and injury in hematopoietic cell transplantation DN O’Dwyer, X Zhou, CA Wilke, M Xia, NR Falkowski, KC Norman, ... American Journal of Respiratory and Critical Care Medicine 198 (10), 1312-1321, 2018 | 45 | 2018 |
First-onset herpesviral infection and lung injury in allogeneic hematopoietic cell transplantation X Zhou, DN O’Dwyer, M Xia, HK Miller, PR Chan, K Trulik, MM Chadwick, ... American journal of respiratory and critical care medicine 200 (1), 63-74, 2019 | 37 | 2019 |
Frailty and geriatric conditions in older patients with idiopathic pulmonary fibrosis JS Sheth, M Xia, S Murray, CH Martinez, CA Meldrum, EA Belloli, ... Respiratory medicine 148, 6-12, 2019 | 37 | 2019 |
Possible UIP pattern on high-resolution computed tomography is associated with better survival than definite UIP in IPF patients ML Salisbury, LB Tolle, M Xia, S Murray, N Tayob, AM Nambiar, ... Respiratory medicine 131, 229-235, 2017 | 36 | 2017 |
Randomized phase 2 studies of checkpoint inhibitors alone or in combination with pegilodecakin in patients with metastatic NSCLC (CYPRESS 1 and CYPRESS 2) D Spigel, R Jotte, J Nemunaitis, M Shum, J Schneider, J Goldschmidt, ... Journal of Thoracic Oncology 16 (2), 327-333, 2021 | 31 | 2021 |
NT-proBNP in stable COPD and future exacerbation risk: Analysis of the SPIROMICS cohort WW Labaki, M Xia, S Murray, JL Curtis, RG Barr, SP Bhatt, ER Bleecker, ... Respiratory medicine 140, 87-93, 2018 | 29 | 2018 |
LIBRETTO-531: a phase III study of selpercatinib in multikinase inhibitor-naïve RET-mutant medullary thyroid cancer LJ Wirth, MS Brose, R Elisei, J Capdevila, AO Hoff, MI Hu, M Tahara, ... Future Oncology 18 (28), 3143-3150, 2022 | 25 | 2022 |
Transbronchial biopsy in the management of pulmonary complications of hematopoietic stem cell transplantation DN O'Dwyer, AS Duvall, M Xia, TC Hoffman, KS Bloye, CA Bulte, X Zhou, ... Bone marrow transplantation 53 (2), 193-198, 2018 | 24 | 2018 |